azomycin has been researched along with amphotericin b in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Evans, WK; Stewart, DJ | 1 |
| Abitbol, H | 1 |
| Cury, AE; Hirschfeld, MP | 1 |
| Assreuy, J; Calixto, JB; Corrêa, R; Eger-Mangrich, I; Grisard, EC; Guzela, M; Lunardi, F; Rodrigues, AT; Santos, AR; Steindel, M | 1 |
| Morilla, MJ; Romero, EL | 1 |
| Dias Filho, BP; Kaneshima, EN; Nakamura, CV; Sarragiotto, MH; Silva, SO; Tonin, LT; Ueda-Nakamura, T; Valdez, RH; Yamada-Ogatta, SF; Yamauchi, LM | 1 |
| Carlier, Y; Cencig, S; Coltel, N; Truyens, C | 1 |
| Barrett, MP; Croft, SL | 1 |
| Bandyopadhyay, D; Banik, BK; Nogueda-Torres, B; Rivera, G; Samano, S; Sanchez-Torres, LE; Villalobos-Rocha, JC | 1 |
| Chattopadhyaya, J; Dixit, SS; Földesi, A; Upadhayaya, RS | 1 |
3 review(s) available for azomycin and amphotericin b
| Article | Year |
|---|---|
Non-chemotherapeutic agents that potentiate chemotherapy efficacy.
Topics: Adult; Amphotericin B; Animals; Antimetabolites; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Buthionine Sulfoximine; Calcium Channel Blockers; Calmodulin; Cardiotonic Agents; Child; Clinical Trials as Topic; Dipyridamole; Drug Evaluation; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Female; Humans; Ketoconazole; Male; Methionine Sulfoximine; Mice; Neoplasms; Nitroimidazoles; Xanthines | 1989 |
Nanotechnological approaches against Chagas disease.
Topics: Amphotericin B; Animals; Chagas Disease; Chemistry, Pharmaceutical; Developing Countries; Drug Delivery Systems; Heart; Humans; Lactic Acid; Liposomes; Microspheres; Nanoparticles; Nanotechnology; Nitroimidazoles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Trypanocidal Agents; Trypanosoma cruzi | 2010 |
Management of trypanosomiasis and leishmaniasis.
Topics: Administration, Oral; Africa; Amphotericin B; Antiprotozoal Agents; Benzamides; Boron Compounds; Chagas Disease; Drug Therapy, Combination; Humans; India; Leishmaniasis; Nitroimidazoles; Pentamidine; Triazoles; Trypanosomiasis, African | 2012 |
1 trial(s) available for azomycin and amphotericin b
| Article | Year |
|---|---|
Non-chemotherapeutic agents that potentiate chemotherapy efficacy.
Topics: Adult; Amphotericin B; Animals; Antimetabolites; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Buthionine Sulfoximine; Calcium Channel Blockers; Calmodulin; Cardiotonic Agents; Child; Clinical Trials as Topic; Dipyridamole; Drug Evaluation; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Female; Humans; Ketoconazole; Male; Methionine Sulfoximine; Mice; Neoplasms; Nitroimidazoles; Xanthines | 1989 |
8 other study(ies) available for azomycin and amphotericin b
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
[Treatment of Chagas disease].
Topics: Amphotericin B; Animals; Chagas Disease; Drug Evaluation, Preclinical; Mice; Nifurtimox; Nitroimidazoles; Trypanocidal Agents | 1981 |
Interactions between amphotericin B and nitroimidazoles against Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Candida albicans; Drug Synergism; Microbial Sensitivity Tests; Nitroimidazoles | 1997 |
Trypanocidal and leishmanicidal properties of substitution-containing chalcones.
Topics: Amphotericin B; Animals; Chalcone; Dose-Response Relationship, Drug; Leishmania braziliensis; Nitroimidazoles; Structure-Activity Relationship; Trypanosoma cruzi | 2003 |
In vitro and in vivo trypanocidal synergistic activity of N-butyl-1-(4-dimethylamino)phenyl-1,2,3,4-tetrahydro-β-carboline-3-carboxamide associated with benznidazole.
Topics: Amphotericin B; Animals; Body Weight; Carbolines; Cell Count; Cell Line; Chagas Disease; Drug Combinations; Drug Resistance; Drug Synergism; Haplorhini; Heart; Humans; Ketoconazole; Life Cycle Stages; Male; Mice; Mice, Inbred BALB C; Nitroimidazoles; Survival Rate; Trypanocidal Agents; Trypanosoma cruzi | 2012 |
Evaluation of benznidazole treatment combined with nifurtimox, posaconazole or AmBisome® in mice infected with Trypanosoma cruzi strains.
Topics: Amphotericin B; Animals; Chagas Disease; Disease Models, Animal; DNA, Protozoan; Drug Therapy, Combination; Female; Mice; Mice, Inbred BALB C; Nifurtimox; Nitroimidazoles; Parasite Load; Parasitemia; Real-Time Polymerase Chain Reaction; Treatment Outcome; Triazoles; Trypanocidal Agents; Trypanosoma cruzi | 2012 |
A Practical Green Synthesis and Biological Evaluation of Benzimidazoles Against Two Neglected Tropical Diseases: Chagas and Leishmaniasis.
Topics: Amphotericin B; Antiprotozoal Agents; Benzimidazoles; Chagas Disease; Green Chemistry Technology; Heating; Leishmania mexicana; Leishmaniasis; Microwaves; Nifurtimox; Nitroimidazoles; Trypanosoma cruzi | 2017 |
New antiprotozoal agents: their synthesis and biological evaluations.
Topics: Amphotericin B; Antiprotozoal Agents; Cell Line; Cell Survival; Humans; Leishmania infantum; Nifurtimox; Nitroimidazoles; Parasitic Sensitivity Tests; Quinolines; Structure-Activity Relationship; Trypanosoma brucei brucei; Trypanosoma brucei rhodesiense; Trypanosoma cruzi | 2013 |